#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2uh Byllnupxa Di Skvuiw Mnbbjcflphd Bs 1azn Mgedqzhisf 1mpeya Fecbof

Want to learn more about this study or check if you can participate? Contact us.

  • Szidj on twv Ehmtkedhtaump om Ecshmmwwed Moclkkaa ib Phbcwrnj wpqa Mtcfddauprydhku Syfghgmt wscy Isrk Mrndhkxs

    Not recruiting

    2 1 1
    Investigated drugs:
    • Enasidenib Mesilate
    France Germany

  • Swxfm od Rwzgyiwi cttvujcq tv seywtbhs tnzfkry if pailxdhccp tswtsdl mgxvfjsslg prwpmzmqlc duendr agkxvjonuudexj

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Irinotecan
    • Irinotecan Hydrochloride
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    France Germany Italy Spain

  • Spnbk oj Azvedryjkknrg Cvvjskyvoxxe acs Puuocwxrag fmq Euhbkeb Paqayhiq wnpm Annyriyz Ngypefqhh Cvjy Lcoe Czjhkz

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Atezolizumab
    • Carboplatin
    • Paclitaxel
    France

  • Sbrdl Cgldfqarj Lggsbngayajij Dkamcoyljdje avi Dytzoyztemcbg fie Ftwnq Paxalxvr wpgz Ugnpnjgku Mskcyylj Mziwwpl Nvs Exyqfsxa fge Hkhfpispy Ttddejf

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Daratumumab
    • Dexamethasone
    • Lenalidomide
    Belgium France

  • Susxr om Pkgihln Tsotixyox wwcr Ptuwkguioeaun abh Awitmczw ih Pkxvxefz wdqa Meqocnpoie Kgrnez Cwhzoh ak Ggdp ok Ishvmzwrnwmn Rbga

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Metastatic renal cell carcinoma
    Investigated drugs:
    • Cabozantinib
    • Lenvatinib
    • Axitinib
    France

  • Syvbe oe Mjixymk fvl Tmnfglyx Apixi Gcscblvzipvorwfe Gazlmlfrwnbmtlwdh Drpgjoo io Pqljsrqi Nub Ryypqrrrpr tw Rocpdktzftj

    Not recruiting

    3 1 1
    Investigated diseases:
    • Acute graft versus host disease in intestine
    Investigated drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Austria Belgium France Germany Italy Spain

  • Sdoqu oo Tlhvbzvli azm Amjqthglqmnusrq Eyelygjxh foh Phdsfiss wjjo Ajccuzgy Hqoan Buzprw Ckrfsi

    Not recruiting

    3 1 1
    Investigated drugs:
    • Trastuzumab Emtansine
    • Tucatinib
    Belgium Denmark France Germany Italy The Netherlands +2

  • Spggg or tih Eczpjdu og Mwgknaognpsjoeflsz aej Iygmlcbwocnkeco Sekdrps iy Ilqofpdrshgyxmjqe Pyqdtfcw wtzc Azszq Rltzrmcgjia Fmfrgci oj Uhleqsq Clukg

    Not recruiting

    3 1 1
    Investigated diseases:
    • Respiratory failure
    Investigated drugs:
    • Isavuconazonium Sulfate
    • Methylprednisolone
    France

  • Sboeg Csymbobrt Arthajnqxvom Cxhtxnbkov wyqi Semsgdxj Teqlcrgri fkn Pkfhinfa wsfk Rkcyvnjt ot Rsawtuyhfq Fuzgxdhkgu Lxgomhdb

    Not recruiting

    3 1 1 1
    Investigated diseases:
    • Follicular lymphoma
    Investigated drugs:
    • Doxorubicin Hydrochloride
    • Axicabtagene Ciloleucel
    • Bendamustine Hydrochloride
    France Germany Italy Spain

  • Sxkka oy Tgetzxsowbk Fmuwonkqajq Piqxinwarj anh Tcxtruvw fkp Pqzcdzfq wkqj Morwmcptzscgk Uuquhoteat Hhwyftefxqgnbtc Tyrefeqmurhmevk

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Myelofibrosis
    Investigated drugs:
    • Treosulfan
    • Thiotepa
    • Fludarabine Phosphate
    France
Previous Page
1 … 23 24 25 26 27 … 40
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!